Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on January 10, 2026, the Compensation Committee of the Board of Directors granted non-qualified stock option awards to purchase an ...
Precipio, Inc., a specialty cancer diagnostics company, announced that it granted stock options to its senior management on January 14, which will vest only if the company's stock price exceeds $30.30 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback